Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 750-759

  Kumaraguru, Udayasankar ^a   Rouse, Richard J D ^b   Nair, Smita K ^c   Bruce, Barry D ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHAPERONE; DNA VACCINE; PLASMID DNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOGENICITY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

EID: 0034661654     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.750     Document Type: Article

References (42)

1. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against a lethal influenza virus challenge by immunization with hemagglutinin-expressing plasmid DNA. Vaccine 11:975.
2. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Feigner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465.
3. Doe, B., M. Selby, S. Barnett, J. Baenziger, and C. M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93:8578.
4. Donnelly, J. J., A. Friedman, D. Martinez, D. L. Montogomery, J. W. Shiver, S. L. Motzel, J. B. Ulmer, and M. A. Liu. 1995. Preclinical efficacy of prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:583.
5. Casares, S., K. Inaba, T.-D. Brumeanu, R. M. Steinman, and C. A. Bona. 1997. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186:1481.
6. Rouse, R. J. D., S. K. Nair, S. Lydy, J. C. Bowen, and B. T. Rouse. 1994. Induction of primary cytotoxic T lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol. 68:5685.
7. Torres, C. A. T., A. Iwasaki, B. H. Barber, and H. L. Robinson. 1997. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:4529.
8. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617.
9. Steinman, R. M. 1996. Dendritic cells and immune-based therapies. Exp. Hematol. 24:859.
10. Steinman, R. M., M. Witmer-Pack, and K. Inaba. 1993. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329:1.
11. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation, and antigen presenting functions of dendritic cells. Curr. Opin. Immunol. 9:10.
12. Witmer-Pack, M. D., M. T. Crowley, K. Inaba, and R. M. Steinman. 1993. Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ. J. Cell Sci. 105:965.
13. Xiang, Z. Q., S. L. Spitalnik, J. Cheng, J. Erikson, B. Woyczyk, and H. C. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209: 569.
14. Bevan, M. J. 1995. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182:639.
15. Pfeifer, J. D., M. J. Wick, R. L. Robert, K. Findlay, S. J. Mormark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359.
16. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class-I-restricted CTLs. Nature 392:86.
17. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
18. Craig, E. A., J. Kramer, J. Shilling, M. Werner-Washburne, S. Holmes, J. Kosic-Smithers, and C. M. Nicolet. 1989. SSCI, an essential members of the yeast hsp70 multigene family, encodes a mitochondrial protein. Mol. Cell. Biol. 9:3000.
19. Nair, S. K., F. Zhou, R. Reddy, L. Huang, and B. T. Rouse. 1992. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary CTL responses in vivo. J. Exp. Med. 175:609.
20. Rock, K. L., L. Rothstein, and S. Gamble. 1990. Generation of class I MHC-restricted T-T hybridomas. J. Immunol. 145:804.
21. + T lymphocytes. J. Immunol. 155:259.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Detection and analysis of protein expressed from cloned genes. In Molecular Cloning: A Laboratory Manual. Vol. 3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 18.56-18.57.
23. Pozsgay, M., C. Michaud, M. Liebman, and M. Oslowski. 1986. Substrate and inhibitor studies of thermolysin-like neutral metalloendopeptidase from kidney membrane fractions: comparison with bacterial thermolysin. Biochemistry 25:1292.
24. Srivastava, P. K. 1993. Peptide binding heat-shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv. Cancer Res. 62:153.
25. Heike, M., B. Noll, and K.-H. Meyer zum Büschenfelde. 1996. Heat shock protein-peptide complexes for use in vaccines. J. Leukocyte Biol. 60:153.
26. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo Jr. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1122.
27. Chattergoon, M. A., T. M. Robinson, J. D. Boyer, and D. B. Weiner. 1998. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J. Immunol. 160:5707.
28. Chun, S., M. Daheshia, S. Lee, S. K. Eo, and B. T. Rouse. 1999. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10. J. Immunol. 163:2393.
29. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
30. Zhu, X., X. Zhao, W. F. Burkholder, A. Gragerov, C. M. Ogata, M. E. Gottesman, and W. A. Hendrickson. 1996. Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272:1606.
31. Flaherty, K. M., D. B. McKay, W. Kabsch, and K. C. Holmes. 1991. Similarity of the three-dimensional structures of actin and the ATPase fragment of a 70-kDa heat shock cognate protein. Prof. Natl. Acad. Sci. USA 88:5041.
32. Flynn, G. C., T. G. Chappell, and J. E. Rothman. 1989. Peptide biding and release by proteins implicated as catalysts of protein assembly. Science 245:385.
33. + but not ATP hydrolysis. Nature 365:664.
34. Panaretou, B., C. Prodromou, S. M. Roe, R. O'Brien, J. E. Ladbury, P. W. Piper, and L. H. Pearl. 1998. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 17:4829.
35. Obermann, W. M., H. Sondermann, A. A. Russo, N. P. Pavletich, and F. U. Hartl. 1998. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell Biol. 143:901.
36. Wearsch, P. A., and C. V. Nicchitta. 1997. Interaction of endoplasmic reticulum chaperone GRP94 with peptide substrates in adenine nucleotide-independent. J. Biol. Chem. 272:5152.
37. Jakob, U., T. Scheibel, S. Bose, J. Reinstein, and J. Buchner. 1996. Assessment of the ATP binding properties of Hsp90. J. Biol. Chem. 271:10035.
38. Scheibel, T., T. Weikl, and J. Buchner. 1998. Two chaperone sits in Hsp20 differing in substrate specificity and ATP dependence. Proc. Natl. Acad. Sci. USA 95:1495.
39. Udono, H., and P. K. Srivastava. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152: 5398.
40. Babu, S., and P. K. Srivastava. 1999. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor and peptide specific immunity. J. Exp. Med. 189:797.
41. Nair, S., P. A. Wearsch, D. A. Mitchell, J. J. Wassenberg, E. Gilboa, and C. V. Nicchitta. 1999. Calreticulin displays in vivo peptide binding activity and can elicit cytotoxic T lymphocyte responses against bound peptides. J. Immunol. 162:6426.
42. Vanbuskirk, A., B. L. Crump, E. Margoliash, and S. K. Pierce. 1989. A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. J. Exp. Med. 170:1799.